Biohaven (BHVN) catalysts

Upcoming FDA decisions and readouts we track for Biohaven, each with the filing that announced it.

Listed on — NYSE Catalysts tracked — 1 Rows last checked — 24 Oct 2026

FreeBioList tracks 1 upcoming catalyst for Biohaven (BHVN, listed on NYSE). It concerns Vyglxia (troriluzole) (Spinocerebellar ataxia).

First on the list: the PDUFA date for Vyglxia (troriluzole) (Spinocerebellar ataxia), guided by the company to Q1 2027.

The row links to an SEC filing (8-K or 6-K). It has been verified by a person reading the filing itself, most recently on 24 Oct 2026. The methodology page explains each status.

Background reading: What a PDUFA date is, and why the FDA doesn't publish them.

Ticker: BHVN
Next catalyst: Q1 2027
Type: PDUFA date
Listed options: Not yet checked

Company ▾	Drug ▾	Effect / indication	Next catalyst ▾	Phase / type ▾	Status ▾	Source	Options
Biohaven BHVN · NYSE	Vyglxia (troriluzole)	Spinocerebellar ataxia	Q1 2027 company guidance	PDUFA date	Verified	8-K ↗	—
Notes — Filing states the FDA considers the resubmission "a complete response to the November 4, 2025 action letter, and has assigned a user fee goal date in the first quarter of 2027." The FDA also plans a Peripheral and Central Nervous System Advisory Committee meeting; its date has not been announced. Source: 8-K, filed 22 Oct 2026 · verified 24 Oct 2026

Companies working on related conditions

Lexeo Therapeutics (LXEO)PKP2 arrhythmogenic cardiomyopathy (gene therapy); Friedreich ataxia cardiomyopathy (gene therapy); Friedreich ataxia cardiomyopathy

Also due in Q1 2027

CorMedix (CRMD)PDUFA date for REZZAYO (rezafungin for injection), Q1 2027
Pharming Group (PHAR)PDUFA date for Leniolisib (Joenja) lower doses, 30 Jan 2027
Aquestive Therapeutics (AQST)PDUFA date for Anaphylm (dibutepinephrine) sublingual film, 16 Mar 2027
argenx SE (ARGX)PDUFA date for Efgartigimod (VYVGART / VYVGART Hytrulo), Feb 2027
Belite Bio (BLTE)PDUFA date for Tinlarebant, 12 Feb 2027
Arcutis Biotherapeutics (ARQT)PDUFA date for ZORYVE (roflumilast) cream 0.05%, 23 Feb 2027